ARCHIVES

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

Alan Rabson Named Acting NCI Director

October 5, 2001

UPCI Opens New Facility; Gomella Wins NCI Award.

July 4, 2003

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

Funding Opportunities: Aging Institute Offers Program Announcement

February 6, 1998

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994